Basic Information
Basic information for ZNF213-AS1-226-29aa
Peptide Name ZNF213-AS1-226-29aa
Genome Position chr16:3133334-3133420[-]
Species Human
Peptide Sequence MFTFLCSSRFGHLQCSAVVVAFQFNWETA
Peptide Length 29
Unique No (ZNF213-AS1-210-29aa,ZNF213-AS1-213-29aa-1,ZNF213-AS1-215-29aa-2,ZNF213-AS1-216-29aa,ZNF213-AS1-217-29aa-1,ZNF213-AS1-220-29aa-1,ZNF213-AS1-221-29aa,ZNF213-AS1-223-29aa,ZNF213-AS1-224-29aa-2,ZNF213-AS1-225-29aa)
Grand Average of Hydropathicity 0.6793
Relative Molecular Mass 3832.33
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000263072;ZNF213-AS1
Transcript ID/Name ENST00000671396;ZNF213-AS1-226
Transcript Length 1355
Coding Ability 0.1926
DNA Sequence Corresponding to Peptide ATGTTTACCTTCCTCTGTTCCTCCAGATTTGGACATTTACAGTGTTCAGCCGTTGTTGTGGCATTCCAATTCAATTGGGAAACAGCT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :